融合切片檢查市場規模、佔有率和成長分析：按產品類型、切片檢查途徑、融合技術、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球融合切片檢查市場價值 8 億美元，預計從 2025 年的 8.68 億美元成長到 2033 年的 16.6708 億美元，在預測期（2026-2033 年）內以 8.5% 的複合年成長率成長。

全球融合切片檢查市場的發展動力源自於斷層成像和即時超音波的融合，旨在提高組織取樣的準確性。該市場反映了臨床上迫切需要檢測關鍵癌症並盡可能減少不必要的手術。多參數磁振造影（MRI）的演進和商業化推動了基於軟體的MRI-超音波融合平台的創新。隨著臨床證據影響指南的製定，醫療系統正在整合這些技術，從而促進市場成長。關鍵的成長要素是已證實的臨床價值，這鼓勵了醫院的投資，例如區域醫院診斷流程的改進。人工智慧驅動工具的興起，實現了病灶的自動分割和智慧對齊，推動了對整合系統的需求，這些系統能夠進一步提高診斷準確性，簡化切片檢查，並增強臨床醫生在各種應用中的信心。

全球融合切片檢查市場促進因素

全球融合切片檢查市場的發展主要得益於影像融合技術的顯著進步，該技術能夠改善病灶可視化效果並提高手術精準度。這使得臨床醫生能夠更有信心地進行標靶切片檢查，並獲得更好的診斷結果。先進的軟體演算法以及與超音波、CT 和 MRI 等影像設備的有效整合，提高了工作流程效率，並減少了重複操作的需要。因此，醫療機構逐漸認知到融合切片檢查系統的附加價值，該系統能夠最佳化患者預後並簡化臨床流程。這種對診斷精準度和操作效率提升的日益認可，正在推動醫院和專科診所採用這些創新系統。

全球融合切片檢查市場面臨的限制因素

由於持續存在的監管不確定性和地區報銷政策的差異，全球融合切片檢查市場對醫療服務提供者和製造商都面臨著巨大的挑戰。醫療設備核准和付款方面的不確定性可能導致醫療機構優先選擇保險覆蓋範圍更可靠的傳統診斷方法。因此，製造商面臨更高的商業化風險，並且在應對複雜的核准流程時，市場准入和擴張可能會受到延誤。儘管融合切片檢查技術已展現出顯著的臨床優勢，但這些對基礎設施、培訓和分銷網路投資的限制最終會阻礙其在臨床上的快速和廣泛應用。

全球融合切片檢查市場趨勢

全球融合切片檢查市場正經歷一場重大變革，其驅動力在於人工智慧 (AI) 在診斷流程中日益廣泛的應用。這項變革透過改善影像解讀、提高標靶精準度和最佳化手術流程規劃，顯著提升了工作流程效率。業內企業正積極合作，將先進的分析功能整合到成像技術中，從而實現不同成像模式之間的無縫銜接，並為醫療專業人員提供即時決策支援。使用者友善的介面、可互通的軟體以及對臨床醫生全面培訓的重視，進一步加速了融合活體組織切片技術的普及應用。因此，這一趨勢正在加強醫療設備製造商、軟體開發商和利害關係人之間的夥伴關係，並將重點轉向擴充性的創新解決方案，以增強診斷信心並簡化診療路徑。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球融合切片檢查市場規模：按產品類型分類

• 設備（MRI/超音波融合系統）
• 軟體
• 耗材和配件

全球融合切片檢查市場規模：依切片檢查途徑分類

• 經直腸融合切片檢查
• 經會陰融合切片檢查

全球融合切片檢查市場規模：依融合技術分類

• 基於軟體的融合
• 磁振造影融合
• 認知融合

全球融合切片檢查市場規模：按應用領域分類

• 前列腺癌的診斷
• 其他癌症診斷

全球融合切片檢查市場規模：按最終用戶分類

• 醫院
• 診斷中心
• 專科診所

全球融合切片檢查市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Koninklijke Philips NV
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• FUJIFILM Holdings Corporation
• Canon Inc.
• Hitachi Ltd.
• ESAOTE SpA
• Samsung Medison Co., Ltd.
• BK Medical Holding Company Inc.
• Mindray Medical International Limited
• Koelis
• Eigen
• MedCom GmbH
• Focal Healthcare
• GeoScan Medical
• UC-Care Medical Systems Ltd.
• Biopsee GmbH
• Exact Imaging Inc.
• EDAP TMS SA
• Shenzhen Wisonic Medical Technology Co., Ltd.

結論與建議

Global Fusion Biopsy Market size was valued at USD 800.0 Million in 2024 and is poised to grow from USD 868.0 Million in 2025 to USD 1667.08 Million by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global fusion biopsy market is driven by the integration of cross-sectional imaging and real-time ultrasound for enhanced tissue sampling precision. This market reflects a strong clinical demand for the detection of significant cancers while minimizing unnecessary procedures. The evolution of multiparametric MRI and its commercial applications has spurred innovation in software-based MRI ultrasound fusion platforms. As clinical evidence influenced guidelines, healthcare systems have integrated these technologies, thereby boosting market growth. Key growth factors include demonstrated clinical value that encourages hospital investments, as seen in community hospitals with improved diagnostic pathways. The rise of AI-driven tools for automated lesion segmentation and intelligent alignment further enhances diagnostic accuracy, fostering demand for integrated systems that streamline biopsies and increase clinician confidence across various applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fusion Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fusion Biopsy Market Segments Analysis

Global fusion biopsy market is segmented by product type, biopsy route, fusion technique, application, end-user and region. Based on product type, the market is segmented into Equipment (MRI/Ultrasound Fusion Systems), Software and Consumables & Accessories. Based on biopsy route, the market is segmented into Transrectal Fusion Biopsy and Transperineal Fusion Biopsy. Based on fusion technique, the market is segmented into Software-Based Fusion, In-Bore MRI Fusion and Cognitive Fusion. Based on application, the market is segmented into Prostate Cancer Diagnosis and Other Cancer Diagnostics. Based on end-user, the market is segmented into Hospitals, Diagnostic Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fusion Biopsy Market

The Global Fusion Biopsy market is driven by significant advancements in image fusion technologies that enhance the visualization of lesions and increase procedural accuracy, allowing clinicians to conduct targeted biopsies with greater confidence and better diagnostic results. Enhanced software algorithms and effective integration with imaging modalities such as ultrasound, CT, and MRI improve workflow efficiency and decrease the need for repeat procedures. Consequently, healthcare providers recognize the added value in utilizing fusion biopsy systems, which in turn optimizes patient outcomes and streamlines clinical processes. This growing perception of improved diagnostic precision and operational effectiveness promotes the broader adoption of these innovative systems across hospitals and specialized clinics.

Restraints in the Global Fusion Biopsy Market

The Global Fusion Biopsy market faces significant challenges due to ongoing regulatory uncertainties and varying reimbursement policies, which hinder both providers and manufacturers. This lack of clarity surrounding device approval and payment can lead healthcare facilities to favor traditional diagnostic methods that offer more reliable coverage. Consequently, manufacturers may experience heightened commercialization risks, leading to delays in market entry and scaling operations as they grapple with intricate approval processes. Such constraints on investment in essential infrastructure, training, and distribution networks ultimately restrict the rapid and widespread clinical adoption of fusion biopsy technologies, despite their demonstrated clinical advantages.

Market Trends of the Global Fusion Biopsy Market

The Global Fusion Biopsy market is witnessing a significant transformation driven by the increasing integration of artificial intelligence in diagnostic processes. This evolution is enhancing workflows by improving image interpretation, honing targeting precision, and optimizing procedural planning. Industry players are actively collaborating to incorporate advanced analytics into imaging technologies, facilitating seamless modality fusion and providing real-time decision support for healthcare providers. The emphasis on user-friendly interfaces, interoperable software, and comprehensive clinician training is further accelerating adoption rates. Consequently, this trend fosters strengthened partnerships among device manufacturers, software developers, and clinical stakeholders, while shifting the focus toward scalable, innovative solutions that bolster diagnostic confidence and streamline care pathways.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Fusion Biopsy Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Equipment (MRI/Ultrasound Fusion Systems)
• Software
• Consumables & Accessories

Global Fusion Biopsy Market Size by Biopsy Route & CAGR (2026-2033)

• Market Overview
• Transrectal Fusion Biopsy
• Transperineal Fusion Biopsy

Global Fusion Biopsy Market Size by Fusion Technique & CAGR (2026-2033)

• Market Overview
• Software-Based Fusion
• In-Bore MRI Fusion
• Cognitive Fusion

Global Fusion Biopsy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Prostate Cancer Diagnosis
• Other Cancer Diagnostics

Global Fusion Biopsy Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Specialty Clinics

Global Fusion Biopsy Market Size & CAGR (2026-2033)

• North America (Product Type, Biopsy Route, Fusion Technique, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Biopsy Route, Fusion Technique, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Biopsy Route, Fusion Technique, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Biopsy Route, Fusion Technique, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Biopsy Route, Fusion Technique, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ESAOTE S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BK Medical Holding Company Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koelis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eigen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedCom GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Focal Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeoScan Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UC-Care Medical Systems Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopsee GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Imaging Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Wisonic Medical Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations